• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超声心动图引导下乙醇间隔消融术治疗肥厚型梗阻性心肌病

Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy.

作者信息

Lakkis N M, Nagueh S F, Kleiman N S, Killip D, He Z X, Verani M S, Roberts R, Spencer W H

机构信息

Baylor College of Medicine, Department of Medicine, Cardiology Section, Houston, Tex., USA.

出版信息

Circulation. 1998 Oct 27;98(17):1750-5. doi: 10.1161/01.cir.98.17.1750.

DOI:10.1161/01.cir.98.17.1750
PMID:9788829
Abstract

BACKGROUND

Left ventricular outflow tract (LVOT) obstruction is frequently responsible for symptoms in hypertrophic obstructive cardiomyopathy (HOCM). Medical therapy is often not sufficient to control these symptoms, and surgical myotomy-myomectomy is required.

METHODS AND RESULTS

We enrolled 33 symptomatic patients with HOCM and obstruction (>/=40 mm Hg gradient at rest or >/=60 mm Hg dobutamine-provoked). By contrast echocardiography, the bulging septum was localized and infarcted by injection of 2 to 5 mL of absolute ethanol into the septal artery(ies) supplying the hypertrophied area. Baseline echocardiograms with Doppler, myocardial perfusion tomograms, and treadmill exercise or pharmacological testing were compared with those at 6 weeks and 6 months. The mean rise in creatine kinase was 1964+/-796 U. All patients experienced symptomatic relief; NYHA class decreased from 3. 0+/-0.5 to 0.9+/-0.6 (P<0.001). Exercise time increased from 286+/-193 to 421+/-181 seconds (P=0.03). The resting and dobutamine-provoked gradient decreased from 49+/-33 and 96+/-34 mm Hg to 9+/-19 (P<0.001) and 24+/-31 mm Hg (P<0.001), respectively. Echocardiograms repeated at 6 weeks after the procedure showed a 28% reduction in septal thickness and 17% reduction in left ventricular mass. Myocardial perfusion imaging showed a "septal amputation pattern," with scarring in the upper and middle septal areas. Complete heart block developed in 11 patients, who then required permanent pacemaker implantation.

CONCLUSIONS

Echocardiography-guided ethanol septal reduction in patients with HOCM is a safe, minimally invasive procedure that provides symptomatic relief with improved hemodynamic and left ventricular parameters.

摘要

背景

左心室流出道(LVOT)梗阻是肥厚性梗阻性心肌病(HOCM)患者出现症状的常见原因。药物治疗往往不足以控制这些症状,因此需要进行外科心肌切开-心肌切除术。

方法与结果

我们纳入了33例有症状的HOCM梗阻患者(静息时压差≥40 mmHg或多巴酚丁胺激发时压差≥60 mmHg)。通过对比超声心动图,确定肥厚的室间隔部位,然后向供应肥厚区域的间隔动脉内注射2至5 mL无水乙醇使其梗死。将基线多普勒超声心动图、心肌灌注断层扫描以及平板运动试验或药物试验结果与术后6周和6个月时的结果进行比较。肌酸激酶平均升高1964±796 U。所有患者症状均得到缓解;纽约心脏协会(NYHA)心功能分级从3.0±0.5降至0.9±0.6(P<0.001)。运动时间从286±193秒增加至421±181秒(P=0.03)。静息和多巴酚丁胺激发时的压差分别从49±33 mmHg和96±34 mmHg降至9±19 mmHg(P<0.001)和24±31 mmHg(P<0.001)。术后6周复查超声心动图显示室间隔厚度减少28%,左心室质量减少17%。心肌灌注成像显示“室间隔截断模式”,即室间隔上部和中部出现瘢痕。11例患者发生完全性心脏传导阻滞,随后需要植入永久性起搏器。

结论

超声心动图引导下对HOCM患者进行乙醇室间隔消融术是一种安全的微创手术,可缓解症状,改善血流动力学和左心室参数。

相似文献

1
Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy.超声心动图引导下乙醇间隔消融术治疗肥厚型梗阻性心肌病
Circulation. 1998 Oct 27;98(17):1750-5. doi: 10.1161/01.cir.98.17.1750.
2
Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy.心肌对比超声心动图在肥厚型梗阻性心肌病非手术性室间隔减容治疗中的作用。
J Am Coll Cardiol. 1998 Jul;32(1):225-9. doi: 10.1016/s0735-1097(98)00220-4.
3
Echocardiographic insights into the mechanisms of relief of left ventricular outflow tract obstruction after nonsurgical septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy.超声心动图对肥厚型梗阻性心肌病患者非手术性室间隔减容治疗后左心室流出道梗阻缓解机制的见解。
J Am Coll Cardiol. 2001 Jan;37(1):208-14. doi: 10.1016/s0735-1097(00)01045-7.
4
Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients.经皮腔内室间隔心肌消融术治疗肥厚型梗阻性心肌病:25例患者的急性结果及3个月随访
J Am Coll Cardiol. 1998 Feb;31(2):252-8. doi: 10.1016/s0735-1097(97)00508-1.
5
Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: one-year follow-up.肥厚型梗阻性心肌病的非手术性室间隔减容治疗:一年随访
J Am Coll Cardiol. 2000 Sep;36(3):852-5. doi: 10.1016/s0735-1097(00)00767-1.
6
Early remodelling of left ventricle and improvement of myocardial performance in patients after percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy.肥厚性梗阻性心肌病患者经皮腔内室间隔心肌消融术后左心室的早期重塑及心肌性能改善
Int J Cardiol. 2003 Mar;88(1):27-32. doi: 10.1016/s0167-5273(02)00381-9.
7
Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy.乙醇间隔消融术与外科室间隔切除术治疗肥厚性梗阻性心肌病的比较。
J Am Coll Cardiol. 2001 Nov 15;38(6):1701-6. doi: 10.1016/s0735-1097(01)01614-x.
8
One-year follow-up of percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy in 312 patients: predictors of hemodynamic and clinical response.312例症状性肥厚型梗阻性心肌病患者经皮室间隔消融术的一年随访:血流动力学和临床反应的预测因素
Clin Res Cardiol. 2007 Dec;96(12):864-73. doi: 10.1007/s00392-007-0578-9. Epub 2007 Sep 25.
9
Long-term follow-up after percutaneous septal ablation in hypertrophic obstructive cardiomyopathy.肥厚型梗阻性心肌病经皮室间隔消融术后的长期随访
Clin Res Cardiol. 2007 Dec;96(12):856-63. doi: 10.1007/s00392-007-0579-8. Epub 2007 Sep 27.
10
Complete heart block: determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction therapy.完全性心脏传导阻滞:肥厚型梗阻性心肌病患者接受非手术性室间隔减容治疗的决定因素及临床影响
J Am Coll Cardiol. 2003 Jul 16;42(2):296-300. doi: 10.1016/s0735-1097(03)00623-5.

引用本文的文献

1
Outcome of alcohol septal ablation in mildly symptomatic patients with hypertrophic obstructive cardiomyopathy: A comparison with medical therapy.酒精室间隔消融术治疗症状轻微的肥厚型梗阻性心肌病患者的疗效:与药物治疗的比较。
Clin Cardiol. 2021 Oct;44(10):1409-1415. doi: 10.1002/clc.23697. Epub 2021 Jul 24.
2
A case of ventricular asystole without escape rhythm 4 days after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy with drug-resistant paroxysmal atrial fibrillation.肥厚型梗阻性心肌病伴药物难治性阵发性心房颤动患者经皮腔内室间隔心肌消融术后4天出现无逸搏心律的心室停搏1例。
J Cardiol Cases. 2011 Aug 11;4(2):e110-e114. doi: 10.1016/j.jccase.2011.07.002. eCollection 2011 Oct.
3
Alcohol Septal Ablation after Suboptimal Surgical Septal Myomectomy.
次优手术间隔心肌切除术后酒精间隔消融术
CASE (Phila). 2018 Oct 22;2(5):210-217. doi: 10.1016/j.case.2018.02.004. eCollection 2018 Oct.
4
Application of Large-Scale Aptamer-Based Proteomic Profiling to Planned Myocardial Infarctions.基于大规模适体的蛋白质组学分析在计划性心肌梗死中的应用。
Circulation. 2018 Mar 20;137(12):1270-1277. doi: 10.1161/CIRCULATIONAHA.117.029443. Epub 2017 Dec 8.
5
Complementary Role of Echocardiography and Cardiac Magnetic Resonance in Hypertrophic Cardiomyopathy.超声心动图与心脏磁共振成像在肥厚型心肌病中的互补作用
Curr Cardiol Rep. 2017 Sep;19(9):81. doi: 10.1007/s11886-017-0897-z.
6
Aptamer-Based Proteomic Profiling Reveals Novel Candidate Biomarkers and Pathways in Cardiovascular Disease.基于适配体的蛋白质组学分析揭示心血管疾病中的新型候选生物标志物和途径。
Circulation. 2016 Jul 26;134(4):270-85. doi: 10.1161/CIRCULATIONAHA.116.021803.
7
Echocardiographic profiles in hypertrophic cardiomyopathy: imaging beyond the septum and systolic anterior motion.肥厚型心肌病的超声心动图特征:超越室间隔及收缩期前向运动的成像
Echo Res Pract. 2015 Mar 1;2(1):E1-7. doi: 10.1530/ERP-15-0009. Epub 2015 Feb 25.
8
Percutaneous Septal Ablation in Hypertrophic Obstructive Cardiomyopathy: From Experiment to Standard of Care.肥厚性梗阻性心肌病的经皮室间隔消融术:从实验到治疗标准
Adv Med. 2014;2014:464851. doi: 10.1155/2014/464851. Epub 2014 May 6.
9
Percutaneous transluminal septal myocardial ablation (PTSMA) for symptomatic patients with hypertrophic obstructive cardiomyopathy: first experience.经皮腔内室间隔心肌消融术(PTSMA)治疗症状性肥厚型梗阻性心肌病患者:初步经验。
Neth Heart J. 2001 Nov;9(8):318-321.
10
Percutaneous transluminal septal myocardial ablation in hypertrophic cardiomyopathy.肥厚型心肌病的经皮腔内室间隔心肌消融术
Neth Heart J. 2001 May;9(2):75-77.